環球實業科技(01026.HK):採納股份獎勵計劃
格隆匯 1 月 17日丨環球實業科技(01026.HK)公佈,2021年1月15日,公司採納該計劃作為獎勵,以認可合資格參與者作出的貢獻,以及為集團的持續營運、增長及發展挽留彼等及吸引合適人員。
董事會已將其管理該計劃的權力及權限(包括但不限於根據該計劃就購買、認購、獎勵、歸屬及轉讓股份作出決策)授予管理委員會,而管理委員會由集團並非董事或內幕人士、亦非彼等各自的緊密聯繫人的員工代表組成。
根據計劃規則,概不能作出進一步獎勵以導致根據該計劃授出的股份總數超過於採納日期已發行股份總數10%。為免生疑問,就計算計劃限額(或其任何更新)而言,已授出但已註銷或失效的股份將不會計算在內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.